Image credit: Coleen Danger

Canopy Growth’s US Lobbying Footprint Expands

One of the world’s largest cannabis companies is now lobbying in at least a half dozen states.

Lobbying
New York

New York: Cannabis and the Cuomo Effect

While Cuomo’s scandals might have helped push legalization over the finish line in 2021, the latest fallout could cause delays in setting up the industry.

CBD

Cannabis and Clinical Trials: How the First Cannabis Extract Got FDA Approval

CSU Pueblo hosted a pharmacist at Greenwich Biosciences to talk about the company’s path with Epidiolex, a CBD-based medicine extracted from cannabis plants.